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RESUMO
Introdução: Os resultados a curto prazo da utilização de 
próteses metálicas do cólon seguida de cirurgia eletiva 
(ponte para cirurgia, PPC) na oclusão intestinal por cancro 
colorectal são bem conhecidos. Os resultados oncológicos a 
longo prazo permanecem alvo de discussão e levaram a que, 
recentemente, as sociedades internacionais de endoscopia 
não recomendassem esta estratégia como primeira linha.
Objetivo e Métodos:  Realizámos um estudo longitudinal obser-
vacional de coorte com base nos dados clínicos dos doentes 
tratados na nossa instituição entre 2006 e 2012 (7 anos). 
Analisámos a sobrevida livre de doença (SLD), a sobrevida 
global (SG) e a recidiva como end-points primários. Os dados 
demográficos, o estádio da doença e a morbi-mortalidade 
peri-operatórias foram também comparados.
Resultados: Incluímos 126 doentes, 79 (62,7%) foram tratados 
seguindo uma estratégia PPC (grupo 1) e 47 (37,3%) foram 
submetidos a cirurgia emergente (grupo 2). A distribuição por 
sexo, idade (70,9+/-11,4 anos) e estádio TNM foi semelhante. 
O tempo de follow-up médio foi de 49,2 +/- 3,6 meses. Não 
houve diferenças estatisticamente significativas em relação 
a complicações peri-operatórias (p=0,23) ou realização de 
quimioterapia adjuvante (p=0,53). A incidência de estoma 
definitivo foi superior no grupo 2(p<0,001). A recidiva não foi 
significativamente diferente, apesar de ter sido superior no 
grupo 2 (34,5% vs. 42,5%,p=0,492). A SLD (22,2 vs. 19,7 
meses;p=0,652) e a SG (43,2 vs. 31,9 meses, p=0,096) 
também não foram significativamnete diferentes, embora 
tenham sido ligeiramente superiores no grupo 1.
Conclusões: Os resultados do nosso estudo vão ao encontro 
das meta-análises mais recentes sugerindo que a estratégia 
PPC poderá ser uma alternativa promissora à cirurgia emer-
gente. São necessários ensaios clínicos e estudos prospetivos 
que o comprovem. 
ABSTRACT
Introduction: The short-term results of colonic stenting followed 
by elective surgery (bridge to surgery, BTS) for malignant large-
-bowel obstruction (MLBO) have been well described. However 
long-term oncological outcomes are still debated and interna-
tional endoscopy societies have recently not recommended it 
as a first-line approach.
Aims & Methods: A longitudinal observational cohort study was 
performed based on clinical data review from patients treated 
in our center between 2006 and 2012 (7 years). We analysed 
disease-free survival (DFS), overall survival (OS) and recurrence 
as primary end-points. We also reviewed demographic data, 
disease staging and peri-operatory morbility and mortality.
Results: A total of 126 patients were included: 79 (62,7%) 
were treated with a BTS strategy (group 1) and 47 (37,3%) 
underwent an emergent surgery (group 2). The distribution by 
sex, age (70,9+/-11,4 years) and TNM stage was similiar. The 
median follow-up time was 49,2 +/- 3,6 months. There was no 
significant difference in peri-operatory complications (p=0,23) 
and adjuvant chemotherapy (p=0,53). The need for a definite 
stoma was higher in group 2 (p<0,001). The recurrence did 
not differ significantly between the two groups, although it was 
superior in group 2 (34,5% vs. 42,5%,p=0,492). DFS (22,2 vs 
19,7 months; p=0,652) and OS (43,2 vs. 31,9 months, p=0,096) 
also did not differ signficantly between the two groups, being 
slightly longer in group 1.
Conclusion: Results of our study on oncological outcomes, as 
stated in most recent meta-analysis, as well as well-described 
short-term outcomes, suggest that BTS could be a promising 
alternative strategy for MLBO. Larger prospective studies and 
randomized clinical trials are definetely needed in the future.
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INTRODUCTION
Approximately 10% of patients with colorectal 
cancer (CRC) initially present with malignant 
large-bowel obstruction (MLBO), which in turn 
accounts for 85% of colonic emergencies.1,2 
In Portugal, CCR accounted for 14,9% of all 
oncological related mortality in 2012 (second cau-
se overall), with an incidence of 33,15 /100.000 
inhabitants, according to the National Oncology 
Regist (RON 2014). Also, 10-30% of the cases 
presented with MLBO.3
The standard for management of malignant 
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large-bowel obstruction (MLBO) is emergency 
surgery, which frequently requires stoma creation. 
However, emergency colorectal surgery continues 
to be associated with significant mortality and 
morbidity.4 Furthermore, patients who undergo 
emergency surgery are reported to have poorer 
oncological prognoses than those who undergo 
elective surgery, even for equivalent disease sta-
ges.5,6 Dohmoto et al. first described the placement 
of a self-expandable metallic colonic stent (SEMS) 
for the relief of colonic obstruction in 1991.7,8 
The SEMS is now considered to be a safe and 
effective alternative modality for decompressing 
MLBO, as several meta-analyses have demons-
trated favorable short-term outcomes of SEMS 
insertion followed by surgery, ‘‘bridge to surgery 
(BTS),’’compared with emergency surgery.9–11 
Preoperative SEMS insertion can prevent high-
-risk emergency surgery and may allow elective 
radical surgery following full preoperative staging, 
screening for synchronous proximal lesions, and 
appropriate bowel preparation.12–14 In theory, 
SEMS insertion could have deleterious effects on 
both tumor progression and metastasis, mainly 
due to manipulation of the tumoral mass or even 
undetectable complications (such as microperfo-
rations) but the effect of SEMS on the long-term 
oncological outcome of patients whose disease is 
potentially curable is still unclear.15,16 Until very 
recently, studies evaluating long-term oncological 
effects of BTS were sparse; however, several long-
-term studies were published after 2013 and have 
boosted further debate.17–22. This debate and all 
the concerns about possible worse oncological 
outcomes in patients following a BTS strategy 
ended up driving some international societies 
of endoscopy to ellaborate and publish clinical 
guidelines advising caution when using colonic 
SEMS in a BTS strategy, and pointing them as not 
the first choice in patients believed to be good 
surgical candidates (such as those that are young 
and with low risk according to the American So-
ciety of Anesthesiologists (ASA) Physical Status 
classification system).23
AIMS
The purpose of this study was to compare two 
different strategies when treating obstructive co-
lorectal cancer (colonic stenting as BTS and emer-
gency surgery) in terms of oncological outcomes. 
Disease-free survival (DFS), overall survival (OS) 
and recurrence were considered primary end-
-points. As secondary end-points peri-operative 
morbidity and mortality were performed and 
compared between the two groups.
METHODS
We conducted a longitudinal observational cohort 
study based on clinical data review from patients 
with MLBO treated in our center with a curative 
intent between January 2006 and December 2012 
(seven years) to assess the impact of the two stra-
tegies regarding long-term oncological outcomes. 
Duration of follow-up time and outcomes were 
taken into account until the end of June 2015.
Patients with signs of perforation and peri-
tonitis, with middle and distal rectal cancers or 
right colon cancers (proximal to the distal tran-
verse colon) were excluded as they would not be 
suitable for colonic stent placement according to 
FIGURE 1. Flow-chart of patients
79 BTS
Group 1 
126 Occlusive
CRC
47 Emergent surgery
Group 2
Morbility
Oncological outcomes
(follow-up 49,2±3,6 months)
HFF 2006-2012
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current guidelines.23
The data were collected from medical records, 
procedure and pathology reports.
The age and gender of the patients were recor-
ded as well as the location of colorectal cancers.
Colonic stent placement was performed in an 
emergency setting by certified gastroenterologists 
and using standard endoscopic equipment after 
previous clinical and radiological evaluation. Co-
lonoscopes used were CFQ160AL, Olympus Op-
tical Co.®, Tokyo, Japan and the stents used were 
uncovered self-expandable metal stents Wallflex, 
Boston Scientific®. The diameter and length of 
the stents varied depending on the malignant 
strictures characteristics (location, length) and 
according to the endoscopist preference.
No sedation or sedation using intravenous 
midazolam (performed by a gastroenterologist) 
was administered on a case-to-case basis.
Patient surgical risk was stratified based on 
American Society of Anesthesiology – Physical 
status (ASA) and tumor staging was classified 
according to American Joint Comittee on Cancer 
– TNM system. Peri-operative mordibidity and 
mortality were evaluated according to Clavien-
-Dindo Classification.24
Regarding colonic stent placement, technical 
success was defined as being able to deploy the 
stent adequately across the malignant stricture 
as for clinical sucess we considered resolving 
the obstruction without the need of additional 
measures or treatment.
An oncological surgical resection was perfor-
med according to a protocol varying to the loca-
tion of the tumor and was decided by the surgeon. 
Follow-up protocol for patients after surgery was 
performed according to current guidelines. The 
need for adjuvant chemotherapy was decided 
according to pathological staging, histological 
type of the tumor and patient characteristics 
(co-morbidities) in a case-to-case basis after mul-
tidisciplinary meeting. Stoma reversion surgery 
was performed in selected cases, as a second stage 
surgery, after adjuvant chemotherapy. 
Recurrence after curative resection was defi-
ned as locally or regionally recurrent disease in 
the anastomosis, tumor bed, mesentery, draining 
lymphatics, surgical scar, or port sites. Distant 
metastasis was defined as the spread of the disease 
outside the surgical field to organs such as the 
liver, lungs, bones or brain.
Global recurrence rate during follow-up, type 
of recurrence and OS (survival time from surgery 
until the end of follow-up) as well as DFS (sur-
vival time without recurrence from surgery until 
the end of follow-up) were assessed and compared 
between the groups.
Statistical analysis was performed using IBM 
SPSS version 20.0. X2 test and Mann-Whitney 
tests were used to assess the differences between 
the two groups. P values less than 0.05 were 
considered statistically significant. Kaplan-Meier 
curves were designed to assess survival diferences 
between the 2 groups.
RESULTS
Between January 2006 and December 2012, 126 
patients with MLBO were treated at our institui-
tion with a curative intent. These accounted for 
11,8% of all patients with colorectal cancer treated 
during that given time.
79 patients (62,7%) were treated with colonic 
n TABLE 1 
Distribution according to gender, age and tumor location
Group 1
(n=79)
Group 2
(n=47)
Sex (M/F) 63,3% / 36,7% 57,4/ 42,6% ns
Age (years) 69,3% ± 11,0 72,5 ± 11,7 ns
Tumor location
• Distal transverse /splenic flexure
• Descending colon
• Sigmoid colon
• Proximal rectum 
24,0%
15,2%
55,7%
5,1%
31,9%
10,6%
53,2%
4,3%
ns
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than 2 years) (Figure 1).
Demographic characteristics of the patients 
and tumor distribution according to the location 
are showed in Table I. In both groups there was 
a small predominance of male sex, mean age was 
around 70 years old and the majority of tumors 
were located in the sigmoid colon. There was no 
significant difference between the two groups 
regarding sex, age and tumor location (p=ns).
Distribution of the patients regarding surgi-
cal risk (ASA) and TNM staging are showed in 
Figures 2 and 3. There was also no significant 
difference between the two groups (p=ns).
Regarding colonic stent placement (Table II), 
technical and clinical success were achieved, 
respectively, in 98,7% and 89,9%. Complications 
occured in a total of 7 cases (8,8%) and included 
4 cases of perforation (5%) and 3 cases of stent 
migration (3,8%). Two perforations occured im-
mediately and there were two late perforations 
(9 and 10 days after procedure). There was one 
immediate migration and two late migrations (10 
and 12 days after the procedure).
All complications were managed surgically. 
There was one death related to the procedure 
(1,37%), following perforation and septic shock 
(which was excluded from survival analysis).  
Mean time to surgery was 8,6+/-4,9 days (in-
-hospital stay). In three cases, surgery was per-
formed more than 30 days after stent placement 
due to clinical instability and high surgical risk.
Following surgery, in group 1, a primary anas-
tomosis was achieved in 88% of patients and the 
mean in-hospital stay was 14,4 days and mortality 
FIGURE 2. Distribution of cases according to ASA classification
FIGURE 3. Distribution of tumor staging according to AJCC TNM 
classification
FIGURE 4. Distribution of cases according to Clavien-Dindo 
Classification regarding postoperative complications (I – Any 
deviation from the normal postoperative course withou the 
need for pharmacological treatment or surgical, endoscopic 
or radiological interventions; II – Requiring pharmacological 
treatment; III – Requiring surgical, endoscopic or radiological 
intervention; IV – Life threatning complications requiring 
admission in intermediate / intensive care unit; V- Death)
60
40
20
0
1 2 3 4
% ASA classification (p=0,839)
Group 1 Group 2
60
40
20
0
1 2 3 4
% TMN staging (p=0,309)
Group 1 Group 2
30%
1-2 3-4 5
Clavien – Dindo Classification (p=0,23)
Group 1 Group 2
20%
10%
0%
n TABLE 2 
Results regarding colonic stent placement
Group 1
(n=79)
Technical success 98,7%
Clinical success 89,9%
Complications
- Perforation
- Migration
8,8%
5,0% (n=4)
3,8% (n=3)
Mortality related to the procedure 1,37% (n=1)
Mean time to surgery (days)
8,6 ± 4,9
(in 3 cases > 30 days)
stent placement following a BTS strategy (Group 
1) and in 47 cases (37,3%) emergency surgery was 
performed (Group 2). Outcomes were assessed 
until June 2015 with a mean period of follow-up 
of 49,2 +/- 3,6 months (median follow-up longer 
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was 3,8%. All patients underwent surgery during 
the first admission. 53,9% of patients were offered 
chemotherapy and a definitive stoma was created 
in 13,9%. As for Group 2, primary anastomosis 
was possible in 29,8% of patients, mean in-
-hospital stay was 24,7 days and mortality 11,7%. 
60,0% of patients were offered chemotherapy and 
a definitive stoma was created in 40,4%. Com-
paring the two groups, when colonic stent was 
placed in a BTS strategy, there was a statistacally 
significant higher primary anastomosis rate, lower 
in-hospital stay and mortality and less definitive 
stoma creation (Table III).  
Apart from mortality, as previously mentioned, 
there were no statistically significant diferences 
between groups after distribution according to 
Clavien-     -Dindo Classification (Figure 4).
Regarding oncological outcomes, global recur-
rence of disease was 34,5% in Group 1, lower than 
in Group 2 (42,5%), although this difference was 
not statistically significant (p = 0,492). Distribu-
tion by type of recurrence among the two groups 
is showed in Figure 5 and was similar between the 
two groups in terms of relative incidence.
Both DFS and OS were superior in Group 
1 (22,2 and 43,2 months, respectively) when 
compared with Group 2 (19,7 and 31,9 months), 
although this difference didn’t reach statistic sig-
nificance. OS at the first year was 89% in Group 
1 versus 83% in Group 2. OS at 3 years was 63% 
versus 57% and at 5 years 55% versus 31% (Table 
IV and Figures 6 and 7).
DISCUSSION
Group 1 (BTS strategy) was larger than Group 2 
which probably has to do with the experience our 
hospital as gained in colonic stenting in recent 
years. Treatment was generally decided by surgical 
and gastroenterology teams. However, factors as 
time of the day of the admission, admission on 
FIGURE 5. Total recurrence rate and prevalence of recurrence by type in each group (ns)             
Group 1 Group 2
0
2
4
6
8
10
12
14
%
Peritoneal 
carcinomatosis
Lung Liver Anastomosis Lymph nodes Multiple
Group 1
(n=76)
Group 2
(n=40)
Recurrence 34,5% 42,5% p = 0,492
n TABLE 3 
Postoperative results
Group 1
(n=79)
Group 2
(n=47)
Rate of primary anastomosis 88% 29,8% p < 0,005
In - hospital stay (days) 14,4 24,7 p < 0,01
In-hospital mortality 3,8% 11,7% p < 0,01
Adjuvant chemotherapy 53,9% 60% p < 0,530
Definitive stoma 13,9% 40,4% p < 0,005
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weekends and availability of a gastroenterologist 
proficient in stent placing could have had an im-
portant role and were not possible to analyse. Both 
groups were comparable regarding distribution by 
gender, age, tumor location, disease staging and 
acess to adjuvant chemotherapy. 
Regarding complications of colonic stenting, 
the complication incidence is similiar or lower to 
those reported before.9-11 As for perforation and 
migration, and since there were two late perfo-
rations and two late migrations happening one 
week after the procedure, we can expect that this 
incidence can be lowered if surgery is performed 
in the first week. However, and due to the size 
of our sample, we cannot assume that according 
to statistical analysis. On the other hand, patient 
condition not always allows performing surgery 
as early as wished.
Postoperative results suggest a benefit from the 
BTS strategy in terms of primary anastomosis rate, 
in-hospital stay and mortality as well as definiti-
ve stoma creation. This was expected according 
to short-term results previously published and 
reflect a significative impact in patient quality of 
life, especially if we have into account that these 
patients have already a reduced life expectancy 
and poor outcomes due to advanced stage disease.
Regarding oncological outcomes, recurrence 
did not significantly differ between the two groups 
both in terms of global recurrence and as recur-
rence by location. Based on previous suspicion 
about the deleterious effect of colonic stenting 
regarding tumor manipulation and complications 
we could expect some differences in local recur-
rence (anastomosis or peritoneal carcinomatosis 
alone). However, peritoneal recurrence alone only 
occured in 10,5% of cases in Group 1 compared 
with 7,5% in Group 2. On the other hand, there 
were only two cases of anastomotic recurrence in 
Group 1 (compared to none in Group 2). Inte-
restingly, none of the cases in Group 1 with local 
recurrence happened to have had a perforation 
following stent placement. These data suggest that 
postoperative recurrence and the kind of recur-
rence may depend on many other factors and that 
stenting alone may play a not so important role.
Long-term survival of our sample was poor as 
expected due to advanced disease staging (more 
than 50% were stratified as stage TNM III). Our 
results showed a tendency for longer DFS but 
n TABLE 4 
Mean survival analysis and Kaplan- Meier curves for DFS (left) and OS (right) (ns)
Group 1 Group 2
Mean DFS (months) 22,2 19,7 p=0,652
Mean OS (months) 43,2 31, 9 p=0,096
FIGURES 6 AND 7. Mean survival analysis and Kaplan- Meier curves for DFS (left) and OS (right) (ns)             
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especially longer OS in Group 1, although these 
differences were not statistically significant.
In our experience, SEMS can have a very 
important role in treating occlusive CRC with a 
curative intent and benefit peri-operatory results 
without compromising oncological outcomes. 
Our results show a good technical and clinical 
success combined with less peri-operatory morta-
lity and less need for definite stoma with positive 
impact in patient quality of life.
Our study has some limitations regarding its 
design (retrospective study) which can account 
for some unavoidable selection bias (mainly invol-
ving the decision process regarding the treatment 
and availability for stent placement). Also, there 
are several important questions that can imply 
worsening of oncological outcome and that could 
not be evaluated during our study protocol such 
as the existence of micro-perforations, biological 
factors of bad prognosis and the time “door to 
operating--room” in an emergency setting.
However, we should emphasize the fact that 
we got a good sample size and the existence of a 
relevant percentage of patients younger than 70 
years-old (42,8%; n=54) and ASA < III (> 40%), 
which in theory account for the patients that 
should undergo emergency surgery, according to 
the recent guidelines.
This study represents a real-life setting case-
-based study and, to the best of our knowledge, 
it is the largest Portuguese report in which long-
-term results have been compared between BTS 
and emergency surgery for MLBO. Also, and 
according to the available literature, it is the third 
largest published study with more than two years 
of mean follow-up regarding this issue.22 
The question this study imposes, especially 
regarding similar data on the long-term outcomes 
for SEMS in a BTS strategy, is if there is still enough 
evidence to recommend against SEMS placement 
as a first approach to LBMO due to occlusive CRC.
CONCLUSION
Results of our study on oncological outcomes, as 
stated in most recent meta-analysis and as well 
as well-described short-term outcomes, suggest 
that BTS can be a promising alternative strategy 
for MLBO. Larger prospective studies and rando-
mized clinical trials would be beneficial in order 
to assess impact regarding oncological outcomes. 
However, these studies are very difficult to per-
form and would still need a very long follow-up 
period of time. As for now, we believe these results 
can be better evaluated in each center and there 
is probably insuficient evidence to generally re-
commend against BTS strategy for MLBO, as long 
as there is enough experience with colonic SEMS 
placement and good technical and clinical results 
can be guaranteed.  n
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